DIXIE GROUP INC (DXYN) Fundamental Analysis & Valuation
NASDAQ:DXYN • US2555191004
Current stock price
0.5301 USD
-0.15 (-22.33%)
At close:
0.5495 USD
+0.02 (+3.66%)
After Hours:
This DXYN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DXYN Profitability Analysis
1.1 Basic Checks
- DXYN had negative earnings in the past year.
- DXYN had a negative operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: DXYN reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: DXYN reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.57%, DXYN is doing worse than 68.25% of the companies in the same industry.
- DXYN has a Return On Equity of -4.14%. This is in the lower half of the industry: DXYN underperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.57% | ||
| ROE | -4.14% | ||
| ROIC | N/A |
ROA(3y)-6.01%
ROA(5y)-3.16%
ROE(3y)-39.43%
ROE(5y)-22.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DXYN has a Gross Margin (26.51%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of DXYN has grown nicely.
- DXYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y4.47%
2. DXYN Health Analysis
2.1 Basic Checks
- DXYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- DXYN has less shares outstanding than it did 1 year ago.
- Compared to 1 year ago, DXYN has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.56, we must say that DXYN is in the distress zone and has some risk of bankruptcy.
- DXYN has a Altman-Z score of 0.56. This is amonst the worse of the industry: DXYN underperforms 87.30% of its industry peers.
- DXYN has a Debt/Equity ratio of 3.08. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of DXYN (3.08) is worse than 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.56 |
ROIC/WACCN/A
WACC6.81%
2.3 Liquidity
- DXYN has a Current Ratio of 2.57. This indicates that DXYN is financially healthy and has no problem in meeting its short term obligations.
- DXYN has a Current ratio (2.57) which is in line with its industry peers.
- A Quick Ratio of 0.87 indicates that DXYN may have some problems paying its short term obligations.
- The Quick ratio of DXYN (0.87) is worse than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.57 | ||
| Quick Ratio | 0.87 |
3. DXYN Growth Analysis
3.1 Past
- DXYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.35%, which is quite impressive.
- Looking at the last year, DXYN shows a decrease in Revenue. The Revenue has decreased by -4.36% in the last year.
- Measured over the past years, DXYN shows a decrease in Revenue. The Revenue has been decreasing by -7.36% on average per year.
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.36%
Revenue 1Y (TTM)-4.36%
Revenue growth 3Y3.27%
Revenue growth 5Y-7.36%
Sales Q2Q%-4.73%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. DXYN Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for DXYN. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXYN is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.28 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. DXYN Dividend Analysis
5.1 Amount
- DXYN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DXYN Fundamentals: All Metrics, Ratios and Statistics
0.5301
-0.15 (-22.33%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-08 2024-08-08/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners20.31%
Inst Owner Change0%
Ins Owners10.24%
Ins Owner Change9.28%
Market Cap8.15M
Revenue(TTM)271.04M
Net Income(TTM)-1.13M
Analysts82.86
Price TargetN/A
Short Float %0.04%
Short Ratio0.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.3 | ||
| P/tB | 0.3 | ||
| EV/EBITDA | 13.28 |
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS17.62
BVpS1.78
TBVpS1.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.57% | ||
| ROE | -4.14% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.51% | ||
| FCFM | N/A |
ROA(3y)-6.01%
ROA(5y)-3.16%
ROE(3y)-39.43%
ROE(5y)-22.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y4.47%
F-Score4
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.88 | ||
| Cap/Depr | 23.58% | ||
| Cap/Sales | 0.64% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.57 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.56 |
F-Score4
WACC6.81%
ROIC/WACCN/A
Cap/Depr(3y)41.73%
Cap/Depr(5y)35.72%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%136.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.36%
Revenue growth 3Y3.27%
Revenue growth 5Y-7.36%
Sales Q2Q%-4.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y98.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.38%
FCF growth 3Y-48.2%
FCF growth 5Y9.11%
OCF growth 1Y86.8%
OCF growth 3Y-42.18%
OCF growth 5Y-12.51%
DIXIE GROUP INC / DXYN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DIXIE GROUP INC?
ChartMill assigns a fundamental rating of 1 / 10 to DXYN.
Can you provide the valuation status for DIXIE GROUP INC?
ChartMill assigns a valuation rating of 0 / 10 to DIXIE GROUP INC (DXYN). This can be considered as Overvalued.
How profitable is DIXIE GROUP INC (DXYN) stock?
DIXIE GROUP INC (DXYN) has a profitability rating of 1 / 10.
What is the financial health of DIXIE GROUP INC (DXYN) stock?
The financial health rating of DIXIE GROUP INC (DXYN) is 3 / 10.